Success Metrics

Clinical Success Rate
89.7%

Based on 217 completed trials

Completion Rate
90%(217/242)
Active Trials
9(3%)
Results Posted
66%(144 trials)
Terminated
25(9%)

Phase Distribution

Ph phase_3
84
29%
Ph phase_2
43
15%
Ph phase_1
26
9%
Ph phase_4
93
32%
Ph early_phase_1
2
1%
Ph not_applicable
25
9%

Phase Distribution

28

Early Stage

43

Mid Stage

177

Late Stage

Phase Distribution273 total trials
Early Phase 1First-in-human
2(0.7%)
Phase 1Safety & dosage
26(9.5%)
Phase 2Efficacy & side effects
43(15.8%)
Phase 3Large-scale testing
84(30.8%)
Phase 4Post-market surveillance
93(34.1%)
N/ANon-phased studies
25(9.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.5%

217 of 251 finished

Non-Completion Rate

13.5%

34 ended early

Currently Active

9

trials recruiting

Total Trials

289

all time

Status Distribution
Active(11)
Completed(217)
Terminated(34)
Other(27)

Detailed Status

Completed217
unknown27
Terminated25
Withdrawn9
Active, not recruiting5
Recruiting4

Development Timeline

Analytics

Development Status

Total Trials
289
Active
9
Success Rate
89.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (0.7%)
Phase 126 (9.5%)
Phase 243 (15.8%)
Phase 384 (30.8%)
Phase 493 (34.1%)
N/A25 (9.2%)

Trials by Status

active_not_recruiting52%
completed21775%
unknown279%
withdrawn93%
terminated259%
not_yet_recruiting21%
recruiting41%

Recent Activity

Clinical Trials (289)

Showing 20 of 289 trialsScroll for more
NCT07567781Phase 1

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

Recruiting
NCT07541781Phase 1

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Not Yet Recruiting
NCT02363335Phase 1

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Completed
NCT07390110

Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)

Active Not Recruiting
NCT06246799Phase 3

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Recruiting
NCT06851962Phase 4

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Active Not Recruiting
NCT07417631

Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.

Active Not Recruiting
NCT07417618

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Active Not Recruiting
NCT06263673Phase 4

Anti-Diabetic Medications to Fight PD and LBD

Completed
NCT07096063

Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

Completed
NCT02650427Phase 1

A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection

Completed
NCT07003542Phase 2

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Recruiting
NCT03738878Phase 4

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Terminated
NCT02879409Not Applicable

HbA1c Variability in Type II Diabetes

Active Not Recruiting
NCT06659718

Emulation of the SOUL Diabetes Trial in Healthcare Claims

Completed
NCT04409795Phase 2

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

Completed
NCT02512523Phase 4

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Completed
NCT06054815Phase 2

Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

Completed
NCT04017832Phase 3

A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes

Completed
NCT06587698Not Applicable

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
289